DS
RLAY icon

DRW Securities’s Relay Therapeutics RLAY Stock Holding History

DRW Securities’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,127
Closed -$85.7K – 1651
2025
Q4 		$85.7K Sell
10,127
-24,472
-71% -$175K ﹤0.01% 1080
2025
Q3 		$177K Buy
34,599
+4,956
+17% +$18.9K ﹤0.01% 1105
2025
Q2 		$103K Buy
29,643
+18,886
+176% +$56.2K ﹤0.01% 1017
2025
Q1 		$28.2K Buy
+10,757
New +$42.1K ﹤0.01% 565

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

DRW Securities's RLAY Position: Q1 2026 in Review

DRW Securities sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 10,127 shares — an estimated $85.7K sold.

DRW Securities first reported a position in RLAY in Q1 2025 and held it in 4 quarters. The position peaked at $177K in Q3 2025. 243 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • DRW Securities reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 10,127 Relay Therapeutics shares in Q1 2026, an estimated $85.7K.
  • DRW Securities first reported a position in Relay Therapeutics in Q1 2025 and held it in 4 quarters.
  • DRW Securities's Relay Therapeutics position peaked at $177K in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.